Abstract-Recent studies suggest that many tumors contain a small subset of cells with stem-like properties that are responsible for tumor initiation and progression and resistance to conventional treatments. We aimed to identify the presence of putative cancer stem-like cells in a human osteosarcoma cell line and to evaluate their responsiveness to ionizing radiation. The isolated cells formed sphere-clusters, were positive for mesenchymal stem cell markers, differentiated into osteoblasts and developed tumors in immunocompromised mice. [
The cancer stem cell (CSC) hypothesis proposes a hierarchical organization of cells within the tumor, in which a subset of stem-like cells are responsible for sustaining tumor growth and differentiation. These cells, lying at the apex of the hierarchy, have the ability to self-renew and differentiate, generating the diverse cells comprising the bulk tumor [2] . Over recent years, CSCs have been prospectively isolated from diverse solid tumors, albeit its frequency is highly variable (reviewed in [3] ). The existence of CSCs in solid tumors has been demonstrated in xenotransplantation studies. These studies have also demonstrated the self-renewal ability of CSCs on serial passaging. For example, the inoculation of CSCs derived from breast, brain and colon cancer in immunocompromised mice resulted in the formation of tumor masses [4] .
CSCs have already been identified in bone sarcomas. Cell cultures, from biopsy samples of primary osteosarcoma and chondrosarcoma tumors, were analyzed and revealed the presence of a subset of cells that displayed a positive staining for the mesenchymal stem cell (MSC) markers Stro-1, CD105 and CD44 [5] . Nevertheless, none of the markers used are exclusively expressed by CSCs.
CSCs appear to be relatively resistant to common therapies as compared with their more differentiated tumorigenic counterparts, and are thought to be responsible for tumor regeneration after therapy. Several studies have implicated CSCs in resistance to chemotherapy and radiotherapy [6, 7] . The mechanisms by which CSCs resist to radio or chemotherapy-induced cell killing are not completely understood. However some properties they share with normal stem cells such as quiescent status, the expression of ATPbinding cassette (ABC) drug transporters (e.g. MDR1 and BCRP), altered cell cycle kinetics and higher capacity for DNA repair, appears to be related with their resistant phenotype [8] . It is likely that CSCs can use a combination of several mechanisms that make them relatively resistant to therapy compared to their progeny. Therefore, the identification of the prevalent resistant mechanism operating in a particular case will allow a more rational design of better anticancer strategies.
II. GOALS
The main objectives of this work were the isolation of CSCs in an human OS cell line (MNNG/HOS) using the sphere formation assay; characterization of CSCs in terms of expression of cell surface markers, multilineage differentiation, tumorigenic ability and metabolic activity and evaluation of the sensitivity of CSCs previously isolated to ionizing radiation.
III. MATERIALS AND METHODS

A. Cell culture
The human osteosarcoma cell line MNNG/HOS was obtained from the American Type Culture Collection (ATCC, Rockville, MD). Cells grown in monolayer and were cultured in RPMI-1640 medium (Sigma-Aldrich ® ) containing 10% (v/v) of heat-inactivated fetal bovine serum (FBS, Gibco ® Invitrogen), antibiotic/antimycotic 1% (contains penicillin, streptomycin and amphotericin B, Sigma-Aldrich ® ), at 37°C in a humidified atmosphere with 5% CO 2 and 95% air. Only cells with viability > 90% were used in all the experiments.
B. Isolation of cancer stem-like cells
CSCs were isolated from the MNNG/HOS cell line using the sphere-formation assay in ultra-low attachment surfaces. MNNG/HOS cells with 80% confluence were detached with trypsin-EDTA (Gibco ® Invitrogen) and plated at a density of 6x10 4 ) and human basic fibroblast growth factor 10 ng/mL (bFGF, PeproTech) were added twice a week. Cells were kept at 37°C in a humidified atmosphere of 5% CO 2 and 95% air. After 7-10 days, spheres were removed from suspension culture, allowed to attach to adherent surfaces and cultured in FBS-containing RPMI medium as described for MNNG/HOS cells. After reaching 60-80% confluence, cells were re-seeded as single-cell in isolation conditions for secondary and tertiary sphere forming assays. After two washing steps with PBS (250μL), to remove monoclonal excess, the labeled cells were analyzed by flow cytometry using a BD FACS Canto™ II Flow Cytometer (Becton Dickinson, S.A., USA) and analyzed using the CellQuest software (BD Biosciences).
2) Differentiation capacity of CSCs into osteoblasts:
This study was conducted using the guidelines and products of the STEMPRO ® Osteogenesis Differentiation Kit (Gibco ® Invitrogen).
3) Tumorigenic capacity:
The tumorigenic potential of CSCs was evaluated through their ability to generate tumors after inoculation in athymic mice. The animal maintenance and studies were performed in compliance with the Institutional Guidelines related to the Conduct of Animal Experiments. Sixweek old male athymic Balb/c nu/nu mice, purchased from Charles River Laboratories, were injected subcutaneously (s.c.) with 2.5x10 5 
D. Cellular responses to ionizing radiation
Single-cell suspensions of adherent cells (2x10 4 cells/mL) and of CSCs (1x10 5 cells/mL) were irradiated at a rate of 2.70 Gy/min in a radiotherapy linear accelerator (Clinac 600C, Varian, USA) operating at a mean energy of the X-ray beam of 1.3 MV. Cells were irradiated with 2, 4, 6, 8, 10, 15 and 20 Gy. MNNG/HOS and MNNG/Sar cells were transferred into 24-well cell culture plates at a density of 1x10 4 cells/well and CSCs were plated at a density of 5x10 4 cells/well. The plates were incubated at 37°C in a humidified atmosphere of 5% CO 2 and 95% air. After 7 days, cellular viability was measured using [3-(4,5-Dimethylthiazol-2-yl)-2,5-Diphenyltetrazolium Bromide] (MTT) colorimetric assay. The culture medium of irradiated cells was aspirated and 200μL of MTT 5mg/mL (Sigma-Aldrich ® ) diluted in PBS (pH 7.4) were added to each well. Plates were incubated again in the dark for three hours. Then, were added 200μL of HCl 0.04 M in isopropanol per well and the plate stirred in an automatic plate shaker (DPC PhatoDX Rotator SR2) to dissolve the formazan end-product. Afterwards, 300μL of the content of each well were transferred to a 96-well cell culture plate and the absorbance measured at 570nm (reference filter: 620nm), using an automatic ELISA microplate reader (SLT Spectra-II™ -Austria). Surviving fraction (SF) for each radiation dose (D) was normalized to that of control cells. Cell survival curves were fitted to a linearquadratic model (LQM), defined as
In (1) α represents the probability of occurrence of a DSB induced by one ionizing particle and β represents the probability of two SSB combining and forming a DSB. Nonlinear curve fitting for radiation survival curves was performed using OriginPro 8 (OriginLab Corporation). The median lethal dose (LD 50 , dose required to reduce the fraction of surviving cells to 50%) was determined using α and β parameters obtained with the LQM.
1) Detection of reactive oxygen species (ROS) formation
induced by irradiation was assayed, by fluorescence, using the 2',7'-dichlorofluorescin diacetate dye (H 2 DCFDA, Gibco 
E. Statistical analysis
Data are reported as mean ± standard deviation (S.D.) with n indicating the number of experiments. We used the nonparametric Kruskal-Wallis test for multiple comparisons between multiple cell types throughout different conditions or under the same condition. We used the Mann-Whitney nonparametric test for comparisons between two cell types under the same condition. The non-parametric Friedman test was used for comparisons between different conditions within the same cell type. The p-value < 0.05 was considered statistically significant. All statistical analysis was performed by using the
IV. RESULTS
A. Identification of a cancer stem-like cell population in an osteosarcoma MNNG/HOS cell line
After 2 days of culturing in isolation conditions, MNNG/HOS-derived (Fig. 1A ) cells started to form floating and spherical clones and continued to grow during one week until colonies reached 50-100 μm of diameter (Fig. 1B) . Following transfer to standard adherent conditions, cells started to migrate from the sarcosphere, and to adhere to the substrate assuming a morphological phenotype similar to the original cell line (Fig. 1C) . The propagated cells formed secondary and tertiary colonies (Fig. 1D) with the same efficiency as the previous assay, which confirms their self-renewal capability.
B. Characterization of osteosarcoma cells 1) Expression of mesenchymal stem cell surface markers:
Flow cytometry analysis revealed that CSCs, MNNG/HOS and MNNG/Sar cells were clearly positive for CD90, CD73 and CD13 and weakly positive for CD105. Moreover, the three types of cells lacked the expression of CD34, CD11b, CD45, CD19 and HLA-DR, which excludes the presence of hematopoietic progenitor cells and endothelial cells that are likely to be found in an MSC culture. These results are in agreement with the criteria proposed by the International Society for Cellular Therapy [9] .
2) Differentiation into osteoblasts:
The staining of CSCs with Alizarin Red S have showed the deposition of a mineralized matrix, which demonstrates the osteogenic differentiation potential of CSCs.
3) Metabolic activity: The percentage of [
18 F]FDG uptake in CSCs was significantly lower than in both adherent cells and remained almost the same at any time point (Fig. 2) . At 60 min, the mean values for MNNG/HOS (11.57±3.55 %) and in MNNG/Sar cells (11.27±3.62 %) were about 4-fold higher than that in CSCs (2.94±1.33 %) ( Table I ). These results suggest that the accumulation of [
18 F]FDG is lower in less differentiated cells (CSCs) than that in more differentiated ones (MNNG/HOS and MNNG/Sar).
C. Cellular sensibility to ionizing radiation 1) Survival curves:
CSCs revealed to be more resistant to ionizing radiation than cells derived from monolayer cultures (MNNG/HOS and MNNG/Sar) as depicted in Fig. 3 . The LD 50 for CSCs was 7.96±3.00 Gy, significantly higher than that in MNNG/HOS (3.36±0.55 Gy) and MNNG/Sar (3.12±1.38 Gy) cells (Table II) . The differentiated progeny of CSCs (MNNG/Sar) and parental cells (MNNG/HOS) exhibited a similar sensitivity to radiation. No significant differences were observed on the LD 50 values between MNNG/HOS and MNNG/Sar cells (Table II) . a. Survival parameters were obtained from linear-quadratic model fitting of cell survival curves. Values represent the mean LD50 ± standard deviation of the indicated independent experiments performed in triplicate. Abbreviations: LD50 -median lethal dose, α -probability of occurrence of a DSB induced by one ionizing particle, β -probability of combination of two SSB combine and form a DSB, α/β -dose corresponding to the probability of occurrence of DSB and combination of two SSB being the same, R 2 -Adjusted R-squared; * p<0.05 compared to MNNG/Sar and MNNG/HOS cells.
The radiation survival curve of CSCs showed a shoulder in the linear portion of the curve, the portion that takes into account the lethal damage induced by DSBs. This was not observed in the MNNG/HOS and MNNG/Sar cells. The α/β ratio for CSCs was of 18.16 Gy, 6-fold higher than for MNNG/Sar cells (α/β=3.02 Gy) and nearly 15-fold higher than for the original cell line MNNG/HOS (α/β=1.25 Gy). The higher α/β ratio obtained for CSCs is indicative of their higher resistance to cell death induced by lethal DSBs.
2) Reactive oxygen species generation:
In adherent cells, it was observed a progressive increase in ROS production with doses of radiation. However, the increases in relation to nonirradiated cells were only significant (p<0.05) for doses above 8 Gy. Irradiation did not induce significant increases in ROS production in CSCs (p>0.05) (Fig. 4) .
3) Cell cycle progression:
At 24 hours after irradiation it was observed, for MNNG/HOS cells, a consistent dosedependent G 2 /M cell cycle arrest. A progressive increase in the percentage of cells in the G 2 /M phase was accompanied by a proportional decrease of cells in G 1 phase (Fig. 5A) . After 48 hours, a higher fraction of cells that arrested in G 2 /M phase reentered in the cell cycle, as illustrated by the progressive increase of cells entering in G 1 phase and simultaneous reduction in G 2 /M phase (Fig. 5B) . Although this effect was observed for all radiation doses, for 8 and 10 Gy not all cells re-entered in the cell cycle as a significant fraction of cells remained in the G 2 /M phase. For CSCs, although it has been observed a cell cycle arrest in G 2 /M phase, at 24 hours (Fig. 5C ), this effect was not so prominent as compared with that observed in MNNG/HOS cells. After 48 hours (Fig. 5D) , CSCs have exhibited a cell cycle distribution similar to that of non-irradiated cells.
V. CONCLUSIONS
The capacity to form spherical clones, self-renew and differentiate, are required features to identify stem-like cells in a tumor [10] . We attempted to apply serum deprivation and anchorage-independent conditions to the MNNG/HOS cell line to test whether it contained a cellular subset obeying those properties. These adherent cells have shown to contain a small subpopulation of cells with stem-like properties which had the ability to grow in suspension and to form spheres derived from one single cell that we called cancer stem-like cells (CSCs). The sphere forming capacity of MNNG/HOS cells was observed following several passages from non-adherent to adherent conditions, which demonstrates their self-renew ability. These results are in agreement with others, who reported that osteosarcoma and chondrosarcoma primary cultures had a subset of cells "capable of forming suspended spherical, clonal colonies" [5] . Third generation sarcospheres have shown a high plating efficiency, in standard growth medium supplemented with serum and in adherent flasks. Cells expanded from the spherical clones, acquiring a morphological phenotype and behavior similar to that of the original adherent cells and reached confluence at a similar rate as MNNG/HOS cells. These observations demonstrate the ability of the isolated CSCs to generate differentiated progeny.
Bearing in mind the fact that osteosarcoma is a tumor derived from multipotent MSCs [11] , and due to the lack of a defined set of phenotypic surface markers for CSCs [12] , we attempted to characterize CSCs using markers of MSCs. Both adherent and CSC cells have proven to resemble the surface marker profile of MSC, as measured by flow cytometry.
Moreover, the isolated CSCs have also demonstrated the capacity to differentiate along at least into the osteoblastic lineage, when cultured in specific osteogenic medium. CSCs inoculated in athymic mice have formed macroscopically detected tumor masses, which demonstrate that CSCs have tumorigenic ability. These observation together with the stemlike properties described above demonstrate that osteosarcoma MNNG/HOS cell line contains a subset of cancer cells that have typical properties of stem cells and are highly tumorigenic, which is in agreement with the CSCs model.
[
18 F]FDG accumulates preferentially in cells with high metabolic activity and higher energy requirements as tumor cells. The biological basis for the increased accumulation of [ 18 F]FDG in tumor cells in relation to non-malignant tissues is the upregulation of membrane glucose transporters such as GLUT-1 and GLUT-3 and an increase in rate-limiting enzymes of the glycolytic pathway including hexokinase [13, 14] . The results from radiosensitivity assays clearly demonstrated that cells derived from sarcospheres were more radioresistant than parental MNNG/HOS cells. The median lethal dose for CSCs was about 3-fold higher than that in both types of adherent cells. Moreover, the α/β ratio for CSCs was equally higher, being of 15-fold and 6-fold higher than that of MNNG/HOS and MNNG/Sar cells, respectively. The shoulder that was observed in the survival curves of CSCs is indicative of an enhanced ability to repair potentially lethal damages. This effect was observed at doses between 2-4 Gy, which are the clinically relevant doses used in radiotherapy protocols. These results are in agreement with those obtained by other groups. Reference [15] reported that cancer-initiating cells isolated from breast cancer cell lines were a "relatively radioresistant subpopulation of breast cancer cells" [15] . Reference [7] have also shown that CD133-positive cells were the subpopulation "that confers glioma radioresistance and could be the source of tumor recurrence after radiation" [7] . These observations strongly suggest that CSCs might have enhanced defense mechanisms against radiation-induced damage, compared to non-CSCs tumor cells.
The intracellular levels of ROS induced by ionizing radiation were lower in CSCs, compared with both adherent cells and were not dose-dependent. Although significant differences were only observed for doses above 8 Gy, they suggest that CSCs contain increased expression of free radical scavengers, which may contribute to radioresistance. These results are in accordance with others reported in the literature. Two independent studies performed in breast cancer cell lines, have shown that tumor-initiating cells derived from mammospheres contained lower levels of ROS after irradiation, when compared with non-CSCs and are more radioresistant [15, 16] . The lower levels of ROS in CSCs suggest that they could maintain higher oxidative stress resistance than more differentiated cells possibly due to the expression of high levels of antioxidant proteins or ROS scavengers. However, further studies are needed to confirm this hypothesis.
The higher percentage of MNNG/HOS cells arresting at G 2 /M phase is probably related with the higher occurrence of DNA DSBs after irradiation. In fact, the linear profile of the cell survival curves together with the low α/β value is indicative of a higher incidence of DSBs in MNNG/HOS cells. However, the recovery that was observed in after 48 hours suggest that MNNG/HOS cells have mechanism of DNA repair able to fix DNA lesions at least for doses below 8 Gy. The slightly alterations in cell cycle progression in CSCs suggest that they have highly activated basal mechanisms of DNA repair and probably enhanced activity of the DNA damage response that may contribute for their higher radioresistance.
The mechanisms underlying the radioresistance of CSCs are not completely understood. However, studies performed in glioma stem cells have shown that they are radioresistant through the preferential activation of the DNA damage checkpoint response and an increase in the DNA repair capacity [7, 17] .
The chromatin condensation in CSCs was visualized for superior doses of irradiation compared to MNNG/HOS cells, which reinforces the high resistance profile of CSCs to radiotherapy, and that the MNNG/HOS cells accumulate DNA lesions that were not repaired and then triggered the apoptotic pathway.
Regarding the results obtained in this study, CSCs resistance to ionizing radiation can be attributed to diverse mechanisms.
Analysis of the constitutive and radiation induced levels of Chk1/2, proteins involved in the DNA damage response, of antioxidant proteins and of antiapoptotic proteins would be valid approaches, which could explain the radioresistant profile exhibited by CSCs.
